Grey Matter Neurosciences
PrivateLast Round
Seed
Dec 1, 2024
Total Funding Raised
$14M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Grey Matter Neurosciences operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Seed round in December 2024.
Grey Matter Neurosciences is a medical technology company developing revolutionary medical devices and drug-device combinations to treat age-related diseases of the brain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Grey Matter Neurosciences Comparables
Compare Grey Matter Neurosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ceretas | 86% | |
| Attune Neurosciences | 78% | |
| NeuroEM Therapeutics | 78% |
For institutional investors. Book with your work email.
Grey Matter Neurosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Grey Matter Neurosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ontario Brain Institute | Seed |
| Wittington Ventures | Seed |
| TIAP | Seed |
| Weston Family Foundation | Seed |
| Ontario Centre of Innovation | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 87% MoM.
- May 15, 2026
Grew 19% QoQ, from 21 to 25 employees.
For institutional investors. Book with your work email.
Grey Matter Neurosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Grey Matter Neurosciences's valuation, stock price, and market status.
Is Grey Matter Neurosciences a public or private company?
Grey Matter Neurosciences is a private company.
What is the current stock price of Grey Matter Neurosciences?
Grey Matter Neurosciences is a private company, so its shares have no public market price. Caplight tracks Grey Matter Neurosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Grey Matter Neurosciences worth (valuation)?
Valuation information for Grey Matter Neurosciences is not publicly available.
Can I buy Grey Matter Neurosciences stock?
Grey Matter Neurosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Grey Matter Neurosciences's last funding round?
Grey Matter Neurosciences's most recent funding round was Seed on December 1, 2024.
Who are the main investors in Grey Matter Neurosciences?
Key investors in Grey Matter Neurosciences include Wittington Ventures.
Will Grey Matter Neurosciences IPO soon?
No public IPO plans have been announced for Grey Matter Neurosciences.
How can I track Grey Matter Neurosciences secondary market activity?
Caplight tracks bids, offers, and trades in Grey Matter Neurosciences's shares on secondary markets.